EAHP 2012 Report – Pain management: a dual perspective
by Zara Qadir – Even with international guidelines for pain treatment, therapy has to be individualised for patients and pharmacists can play an important role in the management… read more.
by Zara Qadir – Even with international guidelines for pain treatment, therapy has to be individualised for patients and pharmacists can play an important role in the management… read more.
by Christine Clark – Standardised injections could improve patient safety. The B Braun satellite symposium, ‘Is Patient Safety Affordable?’ took place at the European Association of Hospital Pharmacists… read more.
by Zara Qadir – Five years of evolution in Hospital Pharmacy. The 40th EAHP meeting provided an opportunity for Tajda Miharija-Gala and Juraj Sykora, Directors of Professional Development,… read more.
by Christine Clark – The Bayer satellite symposium, ‘The new oral anticoagulants: mechanisms, evidence and day-to-day decisions’, was held at the European Association of Hospital Pharmacists Congress in… read more.
by Zara Qadir reporting on the presentation by Professor Petra Thürmann (pictured) from the Philipp Klee-Institute of Clinical Pharmacology at the HELIOS Klinikum Wuppertal in Germany.
by Zara Qadir reporting on the presentation by Yechiel Hekster (pictured), Professor of Clinical Pharmacy, and a member of The Netherlands Medicines Evaluation Board.
Zara Qadir interviews Dr Chantal Bélorgey (pictured), Head of Clinical Trial Development at the French national competent authority, Affsaps (Agence française de sécurité sanitaire des produits).
Emerging uses of EMA Approved Drugs – by Gary Finnegan – Several new medicines have been approved by the European Medicines Agency after recent meetings of its Committee… read more.
Emerging uses of EMA Approved Drugs – by Gary Finnegan – The European Medicines Agency is emerging from a turbulent spell which has seen the departure of one… read more.
World Health Matters (Sweden) – by Gary Finnegan – Scientists in Sweden believe that have identified a set of genetic variations which cause osteoporosis.
Tel Aviv University develops BL-7050 to ease the neuropathic pain of millions of sufferers.
Support is growing for increased collaboration between pharmaceutical companies and patients in research processes worldwide, according to a new report by healthcare intelligence company GBI Research.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.